unknown
Stage
3
Investors
About
BioArctic is a Swedish biopharma company focused on developing disease-modifying treatments for neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS. They leverage research to create innovative drug candidates.
Explore BioArctic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.